Healthcare provider profile · identity verified

Ramon Gerena, MD

Allopathic & Osteopathic Physicians|General Practice · TOA BAJA, PR · NPI 1427111053

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Ramon Gerena, MD received $47.32 in general payments during 2025 across 2 reported records.

PBG PUERTO RICO LLC accounted for 100.0% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 2 associated products.

A separate comparison found the same explicitly named product in public Medicare Part D data: Eliquis.

PBG PUERTO RICO LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ELIQUIS as an associated drug or biological on 738 records involving 435 distinct recipient NPIs. Public Medicare Part D data also shows 116 claims for Eliquis by this doctor in 2024.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$47.32

2 reported records · 1 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
PBG PUERTO RICO LLC	Unresolved — no canonical attribution shown	$47.32	100.0%	2	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$47.32	2

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
NURTEC ODT Normalized: nurtec odt	Drug	PBG PUERTO RICO LLC	$23.78	1	2025
Source payment records 2025-10-22 · PBG PUERTO RICO LLC · $23.78 · Open Payments source
ELIQUIS Normalized: eliquis	Drug	PBG PUERTO RICO LLC	$23.54	1	2025
Source payment records 2025-06-11 · PBG PUERTO RICO LLC · $23.54 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

Open Payments product	Payment year	Part D brand	Part D year	Claims	Match method	Source
ELIQUIS eliquis	2025	Eliquis	2024	116	exact normalized	Medicare Part D

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

Paying company	Payment year	Drug reported by same entity	Open Payments evidence	Part D	Claims	Beneficiaries
PBG PUERTO RICO LLC Exact reporting entity; no affiliate inference	2025	ELIQUIS open payments reported associated product	CMS Open Payments — General Payments 738 supporting records · 435 recipient NPIs · example record 1228798592	Eliquis · 2024 Exact normalized brand match · 1 Part D row	116	28

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Synthroid	Levothyroxine Sodium	1113	224
Gabapentin	Gabapentin	926	214
Losartan Potassium	Losartan Potassium	799	261
Clonazepam	Clonazepam	693	158
Simvastatin	Simvastatin	693	258
Metformin Hcl	Metformin Hcl	542	169
Diclofenac Potassium	Diclofenac Potassium	518	230
Tamsulosin Hcl	Tamsulosin Hcl	516	124
Atorvastatin Calcium	Atorvastatin Calcium	504	197
Pantoprazole Sodium	Pantoprazole Sodium	471	130
Omeprazole	Omeprazole	439	113
Donepezil Hcl	Donepezil Hcl	384	79
Amlodipine Besylate	Amlodipine Besylate	349	117
Tramadol Hcl	Tramadol Hcl	318	77
Metoprolol Succinate	Metoprolol Succinate	313	112
Dexamethasone	Dexamethasone	298	200
Alprazolam	Alprazolam	280	46
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	263	133
Famotidine	Famotidine	263	74
Memantine Hcl	Memantine Hcl	221	41
Montelukast Sodium	Montelukast Sodium	213	67
Ciprofloxacin Hcl	Ciprofloxacin Hcl	212	178
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	200	68
Rosuvastatin Calcium	Rosuvastatin Calcium	190	81
Clopidogrel	Clopidogrel Bisulfate	174	39
Furosemide	Furosemide	172	46
Temazepam	Temazepam	170	37
Sertraline Hcl	Sertraline Hcl	167	31
Lantus	Insulin Glargine,hum.Rec.Anlog	161	38
Glimepiride	Glimepiride	159	52
Paroxetine Hcl	Paroxetine Hcl	145	25
Diclofenac Sodium	Diclofenac Sodium	142	65
Lisinopril	Lisinopril	134	47
Alendronate Sodium	Alendronate Sodium	133	32
Tolterodine Tartrate Er	Tolterodine Tartrate	133	41
Mometasone Furoate	Mometasone Furoate	130	82
Enalapril Maleate	Enalapril Maleate	128	40
Fenofibrate	Fenofibrate	128	45
Glipizide	Glipizide	128	40
Meclizine Hcl	Meclizine Hcl	125	51
Hydrochlorothiazide	Hydrochlorothiazide	120	32
Pentoxifylline	Pentoxifylline	120	33
Eliquis	Apixaban	116	28
Xarelto	Rivaroxaban	115	23
Duloxetine Hcl	Duloxetine Hcl	114	25
Jardiance	Empagliflozin	107	27
Quetiapine Fumarate	Quetiapine Fumarate	102	14
Escitalopram Oxalate	Escitalopram Oxalate	100	26
Farxiga	Dapagliflozin Propanediol	100	31
Levothyroxine Sodium	Levothyroxine Sodium	96	28
Lorazepam	Lorazepam	96	28
Mupirocin	Mupirocin	92	68
Dicyclomine Hcl	Dicyclomine Hcl	91	38
Neomycin-Polymyxin-Hydrocort	Neomycin/Polymyxin B/Hydrocort	88	73
Humalog	Insulin Lispro	82	15
Fluticasone Propionate	Fluticasone Propionate	79	38
Methylprednisolone	Methylprednisolone	79	58
Ibandronate Sodium	Ibandronate Sodium	77	21
Clotrimazole	Clotrimazole	74	36
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	72	19
Irbesartan	Irbesartan	70	27
Triamcinolone Acetonide	Triamcinolone Acetonide	67	39
Finasteride	Finasteride	66	13
Azithromycin	Azithromycin	64	60
Tobramycin-Dexamethasone	Tobramycin/Dexamethasone	61	47
Cefadroxil	Cefadroxil	60	57
Sucralfate	Sucralfate	59	17
Metoprolol Tartrate	Metoprolol Tartrate	57	19
Trazodone Hcl	Trazodone Hcl	56	17
Carvedilol	Carvedilol	54	18
Lansoprazole	Lansoprazole	53	suppressed
Nifedipine Er	Nifedipine	53	17
Atenolol	Atenolol	52	19
Citalopram Hbr	Citalopram Hydrobromide	52	suppressed
Spironolactone	Spironolactone	52	suppressed
Promethazine Hcl	Promethazine Hcl	51	39
Zolpidem Tartrate	Zolpidem Tartrate	51	11
Janumet	Sitagliptin Phos/Metformin Hcl	50	16
Doxazosin Mesylate	Doxazosin Mesylate	48	17
Januvia	Sitagliptin Phosphate	48	suppressed
Bupropion Xl	Bupropion Hcl	47	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	47	16
Buspirone Hcl	Buspirone Hcl	45	suppressed
Nabumetone	Nabumetone	44	17
Neomycin-Polymyxin-Hc	Neomycin/Polymyxin B/Hydrocort	44	31
Valsartan	Valsartan	41	18
Acyclovir	Acyclovir	40	23
Sildenafil Citrate	Sildenafil Citrate	40	13
Levetiracetam	Levetiracetam	39	suppressed
Risperidone	Risperidone	39	suppressed
Terconazole	Terconazole	39	27
Trulicity	Dulaglutide	39	suppressed
Naproxen	Naproxen	38	13
Diclofenac Sodium Er	Diclofenac Sodium	36	20
Mupirocin	Mupirocin Calcium	34	18
Isosorbide Mononitrate Er	Isosorbide Mononitrate	33	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	32	suppressed
Ketorolac Tromethamine	Ketorolac Tromethamine	32	20
Bumetanide	Bumetanide	31	11
Digoxin	Digoxin	31	suppressed
Estazolam	Estazolam	31	suppressed
Hydrocortisone	Hydrocortisone	31	16
Pregabalin	Pregabalin	31	suppressed
Raloxifene Hcl	Raloxifene Hcl	31	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	29	16
Clonidine Hcl	Clonidine Hcl	28	12
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	28	13
Mirtazapine	Mirtazapine	28	suppressed
Allopurinol	Allopurinol	27	suppressed
Lidocaine	Lidocaine	27	suppressed
Rivastigmine	Rivastigmine	27	suppressed
Ropinirole Hcl	Ropinirole Hcl	27	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	26	24
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	25	suppressed
Divalproex Sodium	Divalproex Sodium	25	suppressed
Fluconazole	Fluconazole	25	21
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	25	suppressed
Jentadueto	Linagliptin/Metformin Hcl	25	suppressed
Ketoconazole	Ketoconazole	25	13
Ssd	Silver Sulfadiazine	25	16
Fenofibrate	Fenofibrate Nanocrystallized	24	15
Ibuprofen	Ibuprofen	24	13
Silver Sulfadiazine	Silver Sulfadiazine	24	13
Testosterone Cypionate	Testosterone Cypionate	24	suppressed
Desonide	Desonide	23	11
Prednisone	Prednisone	23	suppressed
Lacosamide	Lacosamide	22	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	21	suppressed
Ezetimibe	Ezetimibe	21	suppressed
Cilostazol	Cilostazol	19	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	19	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	19	suppressed
Tramadol Hcl-Acetaminophen	Tramadol Hcl/Acetaminophen	19	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	18	suppressed
Insulin Glargine	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Memantine Hcl Er	Memantine Hcl	18	suppressed
Tradjenta	Linagliptin	18	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	17	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	17	suppressed
Glipizide Er	Glipizide	17	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Latanoprost	Latanoprost	17	suppressed
Tizanidine Hcl	Tizanidine Hcl	17	suppressed
Amiodarone Hcl	Amiodarone Hcl	16	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	16	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	16	suppressed
Celecoxib	Celecoxib	16	suppressed
Dexlansoprazole Dr	Dexlansoprazole	16	suppressed
Humulin R	Insulin Regular, Human	16	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	16	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	16	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	15	suppressed
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	15	suppressed
Clobetasol Propionate	Clobetasol Propionate	15	suppressed
Meloxicam	Meloxicam	15	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	15	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	15	suppressed
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	14	suppressed
Loperamide	Loperamide Hcl	14	suppressed
Methotrexate	Methotrexate Sodium	14	suppressed
Propranolol Hcl Er	Propranolol Hcl	14	suppressed
Doxepin Hcl	Doxepin Hcl	13	suppressed
Humalog Mix 75-25	Insulin Lispro Protamin/Lispro	13	suppressed
Naproxen Sodium	Naproxen Sodium	13	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	13	suppressed
Ozempic	Semaglutide	13	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	13	suppressed
Premarin	Estrogens, Conjugated	13	suppressed
Procto-Med Hc	Hydrocortisone	13	suppressed
Carbamazepine Er	Carbamazepine	12	suppressed
Ciclopirox	Ciclopirox	12	suppressed
Dutasteride	Dutasteride	12	suppressed
Enulose	Lactulose	12	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	12	suppressed
Insulin Lispro	Insulin Lispro	12	suppressed
Lactulose	Lactulose	12	suppressed
Lamotrigine	Lamotrigine	12	suppressed
Phenobarbital	Phenobarbital	12	suppressed
Potassium Chloride	Potassium Chloride	12	suppressed
Ramipril	Ramipril	12	suppressed
Silodosin	Silodosin	12	suppressed
Suboxone	Buprenorphine Hcl/Naloxone Hcl	12	suppressed
Sulfasalazine	Sulfasalazine	12	suppressed
Flecainide Acetate	Flecainide Acetate	11	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	11	suppressed
Sure Comfort	Syringe And Needle,insulin,1ml	11	suppressed
Viagra	Sildenafil Citrate	11	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$47.32 · 2 records	PBG PUERTO RICO LLC	ELIQUIS, NURTEC ODT	1	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

What role, if any, does Eliquis play in your treatment recommendations for me?
How do you evaluate evidence when you have a financial relationship with PBG PUERTO RICO LLC?
Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error